BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12700003)

  • 1. Heart metabolic disturbances in cardiovascular diseases.
    Carvajal K; Moreno-Sánchez R
    Arch Med Res; 2003; 34(2):89-99. PubMed ID: 12700003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S; Biagioli B
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the control of energy metabolism in mammalian cardiac muscle cells in culture.
    Seraydarian MW
    Recent Adv Stud Cardiac Struct Metab; 1975; 8():181-90. PubMed ID: 1215636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy metabolism in the ischemic heart.
    Rovetto MJ
    Tex Rep Biol Med; 1979; 39():397-407. PubMed ID: 553321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical factors limiting myocardial energy in a chicken genotype selected for rapid growth.
    Nain S; Ling B; Alcorn J; Wojnarowicz CM; Laarveld B; Olkowski AA
    Comp Biochem Physiol A Mol Integr Physiol; 2008 Jan; 149(1):36-43. PubMed ID: 17988909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts.
    Kobara M; Tatsumi T; Matoba S; Yamahara Y; Nakagawa C; Ohta B; Matsumoto T; Inoue D; Asayama J; Nakagawa M
    J Mol Cell Cardiol; 1996 Feb; 28(2):417-28. PubMed ID: 8729072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease.
    Beadle RM; Frenneaux M
    Heart; 2010 Jun; 96(11):824-30. PubMed ID: 20478861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical derangements in ischemic myocardium: the role of carnitine.
    Siliprandi N; Di Lisa F; Toninello A
    G Ital Cardiol; 1984 Oct; 14(10):804-8. PubMed ID: 6240423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart.
    Briede J; Stivrina M; Vigante B; Stoldere D; Duburs G
    Cell Biochem Funct; 2008; 26(2):238-45. PubMed ID: 17990288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic cardiology: the missing link in cardiovascular disease.
    Sinatra ST
    Altern Ther Health Med; 2009; 15(2):48-50. PubMed ID: 19284182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy metabolism in heart failure and remodelling.
    Ingwall JS
    Cardiovasc Res; 2009 Feb; 81(3):412-9. PubMed ID: 18987051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer.
    Dzeja PP; Bortolon R; Perez-Terzic C; Holmuhamedov EL; Terzic A
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10156-61. PubMed ID: 12119406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic toxicity of the heart: insights from molecular imaging.
    Iozzo P
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):147-56. PubMed ID: 20031381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
    Ford WR; Lopaschuk GD; Schulz R; Clanachan AS
    Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathologic modifications in the myocardial levels of adenine nucleotides].
    Rossi A; Aussedat J; Lavanchy N
    Diabete Metab; 1984 Oct; 10(4):260-74. PubMed ID: 6239798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mitochondrial activity in cardiac cells.
    Mela-Riker LM; Bukoski RD
    Annu Rev Physiol; 1985; 47():645-63. PubMed ID: 3888081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of diltiazem on glycolysis and oxidative metabolism in the ischemic and ischemic/reperfused heart.
    Lopaschuk GD; Barr R; Wambolt R
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1220-8. PubMed ID: 1545389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of superoxide dismutase and catalase on myocardial energy metabolism during ischemia and reperfusion.
    Das DK; Engelman RM; Otani H; Rousou JA; Breyer RH; Lemeshow S
    Clin Physiol Biochem; 1986; 4(3):187-98. PubMed ID: 3709036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.